On this page
MOCS2
molybdenum cofactor synthesis 2
The MOCS2 gene provides instructions for producing two proteins essential for the synthesis of molybdenum cofactor, which is crucial for several metabolic enzymes. The MOCS2 gene plays a vital role in human metabolism by directing the creation of two proteins, MOCS2A and MOCS2B.
MOCS2 is located on the long (q) arm of chromosome 5, at band 5q11.2. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 5 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The MOCS2 gene encodes components of an enzyme critical for the biosynthesis of molybdenum cofactor (MoCo). MoCo is a small molecule that acts as a prosthetic group for several human enzymes, including sulfite oxidase, aldehyde oxidase, and xanthine dehydrogenase.
Disruptions in MOCS2 gene function can lead to impaired MoCo production, which in turn affects the activity of these vital enzymes, resulting in severe metabolic dysfunction.
What the gene does
The MOCS2 gene produces two distinct protein subunits, MOCS2A and MOCS2B. These subunits come together to form molybdopterin synthase, an enzyme that catalyses a key step in the molybdenum cofactor biosynthesis pathway. Specifically, molybdopterin synthase is responsible for the second reaction in this multi-step process.
Molybdenum cofactor is an essential component for several enzymes, such as sulfite oxidase, aldehyde oxidase, xanthine dehydrogenase, and mitochondrial amidoxime reducing component (mARC). These enzymes are involved in metabolising various substances within the body, some of which can be toxic if not properly broken down. Therefore, the MOCS2 gene's function is indispensable for maintaining normal metabolic health.
Video: Genetics 101
Chromosome location
The MOCS2 gene is located on chromosome 5 at position 5q11.2. This gene provides the genetic blueprint for proteins that are 188 amino acids in length.
Protein structure
Domain architecture has not been experimentally characterised in detail for this protein.
Key variants
Variants within the MOCS2 gene can impact the structure and function of the MOCS2A and MOCS2B proteins, thereby affecting the synthesis of molybdenum cofactor. Pathogenic variants can disrupt the enzyme's activity, leading to an inability to produce sufficient molybdenum cofactor. This can result in a spectrum of clinical manifestations, particularly affecting neurological development and metabolic processes.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.106_107del | p.Met36fs | Pathogenic/Likely pathogenic | ★★☆☆ | Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B1 |
c.118G>T | p.Glu40Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B1 |
c.164C>G | p.Ser55Ter | Pathogenic | ★★☆☆ | not provided |
c.182_185del | p.Gln61fs | Pathogenic/Likely pathogenic | ★★☆☆ | Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B1 |
c.304G>T | p.Glu102Ter | Pathogenic | ★★☆☆ | Combined molybdoflavoprotein enzyme deficiency |
c.367del | p.His123fs | Pathogenic | ★★☆☆ | not provided |
c.377+1G>A | - | Pathogenic/Likely pathogenic | ★★☆☆ | Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B1 |
c.469dup | p.Thr157fs | Pathogenic/Likely pathogenic | ★★☆☆ | Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B1 |
c.33T>G | p.Tyr11Ter | Pathogenic | ★★☆☆ | Combined molybdoflavoprotein enzyme deficiency |
c.88C>T | p.Gln30Ter | Pathogenic/Likely pathogenic | ★★☆☆ | MOCS2-related disorders |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the MOCS2 gene are known to cause molybdenum cofactor deficiency, specifically classified as type B. This inherited condition follows an autosomal recessive pattern. Individuals affected typically present with severe neurological symptoms, including early-onset seizures and progressive brain dysfunction (encephalopathy), which often proves fatal in early childhood. At least a dozen variants in the MOCS2 gene have been identified as causes of this severe disorder.
Inheritance pattern
Conditions caused by pathogenic MOCS2 variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
The MOCS2 gene is recognised within the NHS Genomic Medicine Service due to its association with severe inherited conditions. It is listed on several NHS England clinical panels, including DDG2P, Early onset or syndromic epilepsy, Foetal anomalies (R21), Intellectual disability, Likely inborn error of metabolism (R98), and Undiagnosed metabolic disorders. This indicates its clinical significance for diagnosis and management within the UK healthcare system.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the main function of the MOCS2 gene?
The MOCS2 gene produces two protein subunits, MOCS2A and MOCS2B, which combine to form molybdopterin synthase. This enzyme is crucial for the second step in the biosynthesis of molybdenum cofactor, a molecule essential for several metabolic enzymes.
What condition is associated with MOCS2 gene variants?
Variants in the MOCS2 gene are associated with molybdenum cofactor deficiency, specifically type B. This is a severe inherited metabolic disorder primarily characterised by early-onset seizures and progressive brain dysfunction.
How is molybdenum cofactor deficiency inherited?
Molybdenum cofactor deficiency caused by MOCS2 gene variants is inherited in an autosomal recessive pattern. This means an individual must inherit two copies of the altered gene (one from each parent) to develop the condition.
References
- Mendel RR. The molybdenum cofactor. The Journal of biological chemistry. 2013. PMID: 23539623
- Leimkühler S, Charcosset M, Latour P. Ten novel mutations in the molybdenum cofactor genes MOCS1 and MOCS2 and in vitro characterization of a MOCS2 mutation that abolishes the binding ability of molybdopterin synthase. Human genetics. 2005. PMID: 16021469
- Leimkuhler S, Freuer A, Araujo JA. Mechanistic studies of human molybdopterin synthase reaction and characterization of mutants identified in group B patients of molybdenum cofactor deficiency. The Journal of biological chemistry. 2003. PMID: 12732628
- Reiss J, Johnson JL. Mutations in the molybdenum cofactor biosynthetic genes MOCS1, MOCS2, and GEPH. Human mutation. 2003. PMID: 12754701